Annual Operating Expenses
$45.90 M
+$5.61 M+13.93%
December 31, 2023
Summary
- As of February 7, 2025, CRDF annual total operating expenses is $45.90 million, with the most recent change of +$5.61 million (+13.93%) on December 31, 2023.
- During the last 3 years, CRDF annual operating expenses has risen by +$26.45 million (+135.97%).
- CRDF annual operating expenses is now at all-time high.
Performance
CRDF Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$12.77 M
+$58.00 K+0.46%
September 30, 2024
Summary
- As of February 7, 2025, CRDF quarterly total operating expenses is $12.77 million, with the most recent change of +$58.00 thousand (+0.46%) on September 30, 2024.
- Over the past year, CRDF quarterly operating expenses has increased by +$1.80 million (+16.47%).
- CRDF quarterly operating expenses is now at all-time high.
Performance
CRDF Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CRDF Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.9% | +16.5% |
| 3 y3 years | +136.0% | +14.5% |
| 5 y5 years | +183.9% | +14.5% |
CRDF Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +57.1% | at high | +40.5% |
| 5 y | 5-year | at high | +171.2% | at high | +208.0% |
| alltime | all time | at high | +1319.1% | at high | +696.7% |
Cardiff Oncology Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.77 M(+0.5%) |
| Jun 2024 | - | $12.71 M(+14.1%) |
| Mar 2024 | - | $11.14 M(+6.2%) |
| Dec 2023 | $45.90 M(+13.9%) | $10.49 M(-4.3%) |
| Sep 2023 | - | $10.96 M(-11.0%) |
| Jun 2023 | - | $12.32 M(+1.5%) |
| Mar 2023 | - | $12.13 M(+27.5%) |
| Dec 2022 | $40.29 M(+37.9%) | $9.52 M(+4.8%) |
| Sep 2022 | - | $9.09 M(-13.7%) |
| Jun 2022 | - | $10.53 M(-5.5%) |
| Mar 2022 | - | $11.15 M(+15.4%) |
| Dec 2021 | $29.21 M(+50.2%) | $9.66 M(+36.3%) |
| Sep 2021 | - | $7.08 M(+1.8%) |
| Jun 2021 | - | $6.96 M(+26.2%) |
| Mar 2021 | - | $5.51 M(-16.7%) |
| Dec 2020 | $19.45 M(+14.9%) | $6.62 M(+47.1%) |
| Sep 2020 | - | $4.50 M(+8.5%) |
| Jun 2020 | - | $4.14 M(-1.1%) |
| Mar 2020 | - | $4.19 M(-4.3%) |
| Dec 2019 | $16.92 M(+4.7%) | $4.38 M(+2.9%) |
| Sep 2019 | - | $4.26 M(+0.0%) |
| Jun 2019 | - | $4.26 M(+5.8%) |
| Mar 2019 | - | $4.02 M(-288.1%) |
| Dec 2018 | $16.17 M(-26.9%) | -$2.14 M(-141.5%) |
| Sep 2018 | - | $5.16 M(+25.8%) |
| Jun 2018 | - | $4.10 M(-6.5%) |
| Mar 2018 | - | $4.39 M(+42.4%) |
| Dec 2017 | $22.12 M | $3.08 M(-43.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $5.49 M(-2.9%) |
| Jun 2017 | - | $5.66 M(-28.3%) |
| Mar 2017 | - | $7.88 M(-6.9%) |
| Dec 2016 | $38.01 M(+52.3%) | $8.47 M(-11.6%) |
| Sep 2016 | - | $9.59 M(-0.9%) |
| Jun 2016 | - | $9.67 M(-5.8%) |
| Mar 2016 | - | $10.27 M(+41.4%) |
| Dec 2015 | $24.96 M(+64.1%) | $7.26 M(+15.4%) |
| Sep 2015 | - | $6.29 M(-4.7%) |
| Jun 2015 | - | $6.60 M(+37.6%) |
| Mar 2015 | - | $4.80 M(+5.6%) |
| Dec 2014 | $15.21 M(+38.9%) | $4.54 M(+13.7%) |
| Sep 2014 | - | $4.00 M(+21.2%) |
| Jun 2014 | - | $3.30 M(-2.2%) |
| Mar 2014 | - | $3.37 M(+16.4%) |
| Dec 2013 | $10.95 M(+106.6%) | $2.90 M(-7.2%) |
| Sep 2013 | - | $3.12 M(+28.8%) |
| Jun 2013 | - | $2.42 M(-3.4%) |
| Mar 2013 | - | $2.51 M(+57.0%) |
| Dec 2012 | $5.30 M(+63.8%) | $1.60 M(+27.8%) |
| Sep 2012 | - | $1.25 M(-2.8%) |
| Jun 2012 | - | $1.29 M(+10.5%) |
| Mar 2012 | - | $1.16 M(+27.8%) |
| Dec 2011 | $3.23 M(-42.7%) | $911.00 K(+15.7%) |
| Sep 2011 | - | $787.20 K(+8.2%) |
| Jun 2011 | - | $727.30 K(-10.1%) |
| Mar 2011 | - | $809.10 K |
| Dec 2010 | $5.64 M | - |
FAQ
- What is Cardiff Oncology annual total operating expenses?
- What is the all time high annual operating expenses for Cardiff Oncology?
- What is Cardiff Oncology annual operating expenses year-on-year change?
- What is Cardiff Oncology quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Cardiff Oncology?
- What is Cardiff Oncology quarterly operating expenses year-on-year change?
What is Cardiff Oncology annual total operating expenses?
The current annual operating expenses of CRDF is $45.90 M
What is the all time high annual operating expenses for Cardiff Oncology?
Cardiff Oncology all-time high annual total operating expenses is $45.90 M
What is Cardiff Oncology annual operating expenses year-on-year change?
Over the past year, CRDF annual total operating expenses has changed by +$5.61 M (+13.93%)
What is Cardiff Oncology quarterly total operating expenses?
The current quarterly operating expenses of CRDF is $12.77 M
What is the all time high quarterly operating expenses for Cardiff Oncology?
Cardiff Oncology all-time high quarterly total operating expenses is $12.77 M
What is Cardiff Oncology quarterly operating expenses year-on-year change?
Over the past year, CRDF quarterly total operating expenses has changed by +$1.80 M (+16.47%)